CD4 and rheumatoid arthritis: In this context, anti-CD3 [46-48], anti-CD4 [42-45], anti-CD20 [53,54], and anti-TNF-α (infliximab [2,50] and adalimumab [51,52]) have been evaluated for imaging of RA, and most perform relatively well.